$STE (Steris Plc)

$STE {{ '2016-08-09T11:08:28+0000' | timeago}} • Announcement

$STE expects total revenue growth in the range of 22-23% for FY17, including about 6% organic revenue growth, down from prior outlook of 25-26% revenue growth and about 7% organic growth. The company continues to expect $15MM in cost synergies as a result of the combination with Synergy and an adjusted effective tax rate of approx. 25% in FY17.

$PG {{ '2017-07-27T12:19:14+0000' | timeago}} • Announcement

$PG expects 1Q18 results to be the lowest organic sales and core EPS growth period of the year, as the period compares against the highest organic growth base period. Top-line headwinds from portfolio choices and the recent Gillette price reduction in the US will primarily impact 1H18 and will annualize as the year progresses.

$PG {{ '2017-07-27T12:18:04+0000' | timeago}} • Announcement

$PG expects FY18 core EPS of 5-7% versus core EPS of $3.92 in FY17. $PG said it expects core EPS growth in FY18 to be driven primarily by core operating profit growth. All-in GAAP earnings per share are expected to decrease 26-28% versus FY17 GAAP EPS of $5.59.

$PG {{ '2017-07-27T12:16:41+0000' | timeago}} • Announcement

$PG expects FY18 organic sales growth in the range of 2-3%. $PG estimates all-in sales growth of about 3% for FY18, which includes a neutral to half-a-percentage point benefit to sales growth from the combined impacts of foreign exchange and acquisitions & divestitures.

$PG {{ '2017-07-27T12:13:23+0000' | timeago}} • Announcement

$PG's Fabric & Home Care segment organic sales rose 5% versus year ago. Fabric Care and Home Care organic sales both increased mid-single digits due to increased volume from product innovation. Baby, Feminine & Family Care segment organic sales were unchanged versus prior year.

$PG {{ '2017-07-27T12:11:45+0000' | timeago}} • Announcement

$PG's Health Care segment organic sales declined 1% for 4Q17. Oral Care organic sales decreased low single digits due to competitive activity and reduced pricing on paste. Personal Health Care organic sales decreased low single digits due to an earlier cough and cold season versus prior year along with reductions in trade inventories.

$PG {{ '2017-07-27T12:10:19+0000' | timeago}} • Announcement

$PG's Beauty segment organic sales for 4Q17 increased 5%. Organic sales were up high single digits in Skin & Personal Care on continued growth of super-premium SK-II skin care brand and higher pricing behind product innovation. Organic sales rose low single digits in Hair Care, on higher pricing across multiple regions and brands.

$PG {{ '2017-07-27T12:08:05+0000' | timeago}} • Infographic

$PG, which had a disappointing sales growth run lately, said Grooming segment organic sales for 4Q17 slid 1%, on lower pricing in Shave Care. Organic sales fell low single digits in Shave Care due to lower pricing in US. Gillette franchise is taking hit from value-based store brands and disruptive online offerings such as $UL's Dollar Shave Club.

$PII {{ '2017-07-27T12:05:16+0000' | timeago}} • Announcement

$PII has declared a regular quarterly cash dividend of $0.58 per share on its common stock. The dividend is payable on September 15, 2017, to shareholders of record as on September 1, 2017.

$PG {{ '2017-07-27T11:44:05+0000' | timeago}} • Infographic

$PG Procter & Gamble Earnings AlphaGraphic: Q4 2017 Highlights

$PG {{ '2017-07-27T11:37:53+0000' | timeago}} • Announcement

Consumer products giant $PG reported a 14% growth in earnings driven by lower costs and expenses. Net income grew 14% to $2.2Bil from last year and EPS increased 19% to $0.82. Core EPS rose 8% to $0.85. Sales remained unchanged at $16.1Bil. Organic sales rose 2% driven by a 2% increase in organic shipment volume.

$EW {{ '2017-07-26T20:43:20+0000' | timeago}} • Announcement

For 3Q17, $EW projects underlying sales, adjusting for the impact of Germany stocking sales consumption, to be between $810-850MM, and adjusted earnings per share of $0.80 to $0.90.

$EW {{ '2017-07-26T20:42:56+0000' | timeago}} • Announcement

For FY17, $EW's full year sales estimate is now at the high end of its previous $3.2-3.4Bil guidance. Edwards Lifesciences Corp is also raising its estimate for FY17 adjusted earnings per share to $3.65-3.85, from $3.43-3.55.

$EW {{ '2017-07-26T20:40:21+0000' | timeago}} • Announcement

With strong demand for TAVR therapy resulted in total sales growth of 15% on an underlying basis, $EW's 2Q17 sales soared 11% to $841.8MM. Net income for the quarter jumped 47% to $186.1MM or $0.86 per diluted share. Adjusted earnings per share grew 42.1% to $1.08 while underlying sales rose 15% to about $864MM.

$IVC {{ '2017-07-25T16:39:52+0000' | timeago}} • Announcement

$IVC received notice from the FDA that the company has successfully satisfied the agency's requirements under the consent decree to resume full operations at its Corporate and Taylor Street manufacturing facility in Elyria, Ohio.

$ENDP {{ '2017-07-21T14:56:21+0000' | timeago}} • Announcement

$ENDP said it will be ceasing operations and closing its manufacturing and distribution facilities in Huntsville, Alabama. The closure is expected to take place over the next 12 to 18 months. These restructuring actions are expected to reduce $ENDP's workforce by about 875 positions and to result in pre-tax restructuring charges of about $325MM.

$ISRG {{ '2017-07-21T12:26:16+0000' | timeago}} • Infographic

$ISRG Intuitive Surgical, Inc. Earnings AlphaGraphics: Q2 2017 highlights

$ISRG {{ '2017-07-20T20:21:13+0000' | timeago}} • Announcement

In 2Q17, $ISRG's service revenue rose 11% to $142MM while instrument and accessory revenue jumped 17% to $398MM. Intuitive Surgical ended the second quarter with $3.4Bil in cash, cash equivalents, and investments.

$ISRG {{ '2017-07-20T20:16:13+0000' | timeago}} • Announcement

In 2Q17, revenue for $ISRG jumped 13% to $756MM while net income soared 20% to $222MM or $5.77 per diluted share. Non-GAAP net income was $228MM or $5.95 per diluted share, with systems revenue increased by approximately 7% to $216MM.

$IDXX {{ '2017-07-18T10:56:31+0000' | timeago}} • Announcement

$IDXX unanimously elected Stuart Essig as a member of the company's BoD, effective July 12, 2017. In connection with Essig's election, the Board also increased its size from 8 to 9 members, effective July 12, 2017. Essig has been the Chairman of Integra LifeSciences Holdings Corp. since 2012.

$PG {{ '2017-07-17T22:15:27+0000' | timeago}} • Announcement

$PG said it continues to execute on bold productivity initiatives and plans to deliver up to $10Bil over the next five fiscal years. The company recently announced a 3% increase to its quarterly dividend, and expects total dividend payments to shareholders of more than $7Bil in FY17.

Recent Transcripts

MTD (Mettler-Toledo International Inc.)
Thursday, July 27 2017 - 8:30pm
JCI (Johnson Controls Inc.)
Thursday, July 27 2017 - 3:00pm
PG (The Procter & Gamble Company)
Thursday, July 27 2017 - 12:30pm
SNN (Smith & Nephew plc)
Thursday, July 27 2017 - 8:00am
EW (Edwards Lifesciences Corp.)
Wednesday, July 26 2017 - 9:00pm
BABY (Natus Medical Inc.)
Wednesday, July 26 2017 - 3:00pm
IART (Integra LifeSciences Holdings Corporation)
Wednesday, July 26 2017 - 12:30pm
ISRG (Intuitive Surgical, Inc.)
Thursday, July 20 2017 - 8:30pm
PII (Polaris Industries Inc.)
Thursday, July 20 2017 - 2:00pm
VRML (Vermillion, Inc.)
Thursday, May 11 2017 - 12:30pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
STE (Steris Plc)
Tuesday, May 9 2017 - 2:00pm
ENDP (Endo International plc)
Tuesday, May 9 2017 - 12:30pm
ATRS (Antares Pharma Inc.)
Tuesday, May 9 2017 - 12:30pm
IVC (Invacare Corporation)
Tuesday, May 9 2017 - 12:30pm
XRAY (DENTSPLY International Inc.)
Tuesday, May 9 2017 - 12:30pm
SNN (Smith & Nephew plc)
Friday, May 5 2017 - 7:30pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 9:00pm
SRCL (Stericycle, Inc.)
Thursday, May 4 2017 - 9:00pm
KAMN (Kaman Corporation)
Thursday, May 4 2017 - 12:30pm

AlphaGraphics you may like